The Biology and Genetics of Suicidality

Biology of Depression: From Novel Insights to Therapeutic Strategies

Volumn , Issue , 2008, Pages 287-316

  Turecki, Gustavo ^a   Lalovic, Aleksandra ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

Biology; Genes; Genetics; Serotonergic system; Transmission

Indexed keywords

EID: 33847029597     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9783527619672.ch11     Document Type: Chapter

References (179)

1. Lonnqvist, j. K., Psychiatric aspects of suicidal behaviour: depression. In: Hawton, K., van Heeringen, K. (Eds.), Suicide and Attempted Suicide. Chichester: Wiley, 2000, p. 107-120.
2. WHO, Preventing Suicide: A Resource for General Physicians. Geneva: World Health Organization, 2000.
3. Maris, R. W, Suicide. Lancet 2002, 360, 319-326.
4. Cavanagh, j. T., Carson, A. j., Sharpe, M., Lawrie, S. M., Psychological autopsy studies of suicide: a systematic review. Psychol. Med. 2003, 33, 395-405.
5. Beck, A. T., Davis, j. H., Frederick, C. j., et al., Classification and nomenclature. In: Resnick, H., Hathorne, B. (Eds.), Suicide Prevention in the Seventies. Washington DC: US Government Printing Office, 1973, p. 7-12.
6. Rosenberg, M. L., Davidson, L. E., Smith, J. C., Berman, A. L., Buzbee, H., Gantner, G., et al., Operational criteria for the determination of suicide. J. Forensic Sci. 1988, 33, 1445-1456.
7. O'Carroll, P. W., Berman, A. L., Maris, R. W., Moscicki, E. K., Tanney, B. L., Silverman, M. M., Beyond the Tower of Babel: a nomenclature for suicidology. Suicide Life Threat. Behav. 1996, 26, 237-252.
8. Beck, A. T., Weissman, A., Lester, D., Trexler, L., Classification of suicidal behaviors., I. I., Dimensions of suicidal intent. Arch. Gen. Psychiatry 1976, 33, 835-837.
9. Paykel, E. S., Rassaby, E., Classification of suicide attempters by cluster analysis. Br. J. Psychiatry 1978, 133, 45-52.
10. Isometsa, E. T., Lonnqvist, J. K., Suicide attempts preceding completed suicide. Br. J. Psychiatry 1998, 173, 531-535.
11. US Public Health Service, The Surgeon General's Call to Action to Prevent Suicide. Washington DC, 1999.
12. Weissman, M. M., Bland, R. C., Canino, G. J., Greenwald, S., Hwu, H. G., Joyce, P. R., et al., Prevalence of suicide ideation and suicide attempts in nine countries. Psychol. Med. 1999, 29, 9-17.
13. Hawton, K., Appleby, L., Platt, S., Foster, T., Cooper, J., Malmberg, A., et al., The psychological autopsy approach to studying suicide: a review of methodological issues. J. Affect Disord. 1998, 50, 269-276.
14. Conwell, U., Duberstein, P. R., Cox, C., Herrmann, J. H., Forbes, N. T., Caine, E. D., Relationships of age and axis I diagnoses in victims of completed suicide: a psychological autopsy study. Am. J. Psychiatry 1996, 153, 1001-1008.
15. Arsenault-Lapierre, G., Kim, C., Turecki, G., 3500 cases of suicide: a systematic review. Submitted.
16. Isometsa, E. T., Psychological autopsy studies: a review. Eur. Psychiatry 2001, 16, 379-385.
17. Guze, S. B., Robins, E., Suicide and primary affective disorders. Br. J. Psychiatry 1970, 117, 437-438.
18. Blair-West, G. W., Mellsop, G. W., Eyeson-Annan, M. L., Down-rating lifetime suicide risk in major depression. Acta Psychiatr. Scand. 1997, 95, 259-263.
19. Brown, G. L., Ebert, M. H., Goyer, P. F., Jimerson, D. C., Klein, W. J., Bunney, W. E., et al., Aggression, suicide, and serotonin: relationships to CSF amine metabolites. Am. J. Psychiatry 1982, 139, 741-746.
20. Apter, A., Plutchik, R., van Praag, H. M., Anxiety, impulsivity and depressed mood in relation to suicidal and violent behavior. Acta Psychiatr. Scand. 1993, 87, 1-5.
21. Plutchik, R., Outward and inward directed aggressiveness: the interaction between violence and suicidality. Pharmacopsychiatry 1995, 28, (Suppl. 2), 47-57.
22. Brent, D. A., Johnson, B. A., Perper, J., Connolly, J., Bridge, J., Bartle, S., et al., Personality disorder, personality traits, impulsive violence, and completed suicide in adolescents. J. Am. Acad. Child Adolesc. Psychiatry 1994, 33, 1080-1086.
23. Mann, J. J., Waternaux, C., Haas, G. L., Malone, K. M., Toward a clinical model of suicidal behavior in psychiatric patients. Am. J. Psychiatry 1999, 156, 181-189.
24. Apter, A., van Praag, H. M., Plutchik, R., Sevy, S., Korn, M., Brown, S. L., Interrelationships among anxiety, aggression, impulsivity, and mood: a serotonergically linked cluster? Psychiatry Res. 1990, 32, 191-199.
25. Stanley, M., Traskman-Bendz, L., Dorovini-Zis, K., Correlations between aminergic metabolites simultaneously obtained from human CSF and brain. Life Sci. 1985, 37, 1279-1286.
26. Asberg, M., Traskman, L., Thoren, P., 5-HIAA in the cerebrospinal fluid: a biochemical suicide predictor? Arch. Gen. Psychiatry 1976, 33, 1193-1197.
27. Asberg, M., Neurotransmitters and suicidal behavior: the evidence from cerebrospinal fluid studies. Ann. NY Acad. Sci. 1997, 836, 158-181.
28. Cooper, S. J., Kelly, C. B., King, D. J., 5-Hydroxyindoleacetic acid in cerebrospinal fluid and prediction of suicidal behavíour in schizophrenia. Lancet 1992, 340, 940-941.
29. Banki, C. M., Arato, M., Papp, Z., Kurcz, M., Biochemical markers in suicidal patients: investigations with cerebrospinal fluid amine metabolites and neuroendocrine tests. J. Affect Disord. 1984, 6, 341-350.
30. Brown, G. L., Goodwin, F. K., Ballenger, J. C., Goyer, P. F., Major, L. F., Aggression in humans correlates with cerebrospinal fluid amine metabolites. Psychiatry Res. 1979, 1, 131-139.
31. Roy-Byrne, P., Post, R. M., Rubinow, D. R., Linnoila, M., Savard, R., Davis, D., CSF 5HIAA and personal and family history of suicide in affectively ill patients: a negative study. Psychiatry Res. 1983, 10, 263-274.
32. Berrettini, W. H., Nurnberger, J. I. Jr., Scheinin, M., Seppala, T., Linnoila, M., Narrow, W., et al., Cerebrospinal fluid and plasma monoamines and their metabolites in euthymic bipolar patients. Biol. Psychiatry 1985, 20, 257-269.
33. Traskman, L., Asberg, M., Bertilsson, L., Sjostrand, L., Monoamine metabolites in CSF and suicidal behavior. Arch. Gen. Psychiatry 1981, 38, 631-636.
34. Roy, A., Agren, H., Pickar, D., Linnoila, M., Doran, A. R., Cutler, N. R., et al., Reduced CSF concentrations of homovanillic acid and homovanillic acid to 5-hydroxyindoleacetic acid ratios in depressed patients: relationship to suicidal behavior and dexamethasone nonsuppression. Am. J. Psychiatry 1986, 143, 1539-1545.
35. Sedvall, G., Fyro, B., Gullberg, B., Nyback, H., Wiesel, F. A., Wode-Helgodt, B., Relationships in healthy volunteers between concentrations of monoamine metabolites in cerebrospinal fluid and family history of psychiatric morbidity. Br. J. Psychiatry 1980, 136, 366-374.
36. Linnoila, M., Virkkunen, M., Scheinin, M., Nuutila, A., Rimon, R., Goodwin, F. K., Low cerebrospinal fluid 5-hydroxyindoleacetic acid concentration differentiates impulsive from non-impulsive violent behavior. Life Sci. 1983, 33, 2609-2614.
37. Rowland, N. E., Carlton, J., Neurobiology of an anorectic drug: fenfluramine. Prog. Neurobiol. 1986, 27, 13-62.
38. Quattrone, A., Tedeschi, G., Aguglia, U., Scopacasa, F., Direnzo, G. F., Annunziato, L., Prolactin secretion in man: a useful tool to evaluate the activity of drugs on central 5-hydroxytryptaminer-gic neurons. Studies with fenfluramine. Br. J. Clin. Pharmacol. 1983, 16, 471-475.
39. Mann, J. J., McBride, P. A., Malone, K. M., DeMeo, M., Keilp, J., Blunted serotonergic responsivity in depressed inpatients. Neuropsychopharmacology 1995, 13, 53-64.
40. Correa, H., Duval, F., Mokrani, M., Bailey, P., Tremeau, F., Staner, L., et al., Prolactin response to D-fenfluramine and suicidal behavior in depressed patients. Psychiatry Res. 2000, 93, 189-199.
41. New, A. S., Trestman, R. L., Mitropoulou, V., Benishay, D. S., Coccaro, E., Silverman, J., et al., Serotonergic function and self-injurious behavior in personality disorder patients. Psychiatry Res. 1997, 69, 17-26.
42. Soloff, P. H., Kelly, T. M., Strotmeyer, S. J., Malone, K. M., Mann, J. J., Impulsivity, gender, and response to fenfluramine challenge in borderline personality disorder. Psychiatry Res. 2003, 119, 11-24.
43. Coccaro, E. F., Siever, L. J., Klar, H. M., Maurer, G., Cochrane, K., Cooper, T. B., et al., Serotonergic studies in patients with affective and personality disorders: correlates with suicidal and impulsive aggressive behavior. Arch. Gen. Psychiatry 1989, 46, 587-599.
44. Malone, K. M., Corbitt, E. M., Li, S., Mann, J. J., Prolactin response to fenfluramine and suicide attempt lethality in major depression. Br. J. Psychiatry 1996, 168, 324-329.
45. Stahl, S. M., The human platelet: a diagnostic and research tool for the study of biogenic amines in psychiatric and neurologic disorders. Arch. Gen. Psychiatry 1977, 34, 509-516.
46. Andres, A. H., Rao, M. L., Ostrowitzki, S., Entzian, W., Human brain cortex and platelet serotonin-2 receptor binding properties and their regulation by endogenous serotonin. Life Sci. 1993, 52, 313-321.
47. Pandey, G. N., Pandey, S. C., Janicak, P. G., Marks, R. C., Davis, J. M., Platelet serotonin-2 receptor binding sites in depression and suicide. Biol. Psychiatry 1990, 28, 215-222.
48. Arora, R. C., Meltzer, H. Y., Serotonin-2 receptor binding in blood platelets of schizophrenic patients. Psychiatry Res. 1993, 47, 111-119.
49. Pandey, G. N., Pandey, S. C., Dwivedi, Y., Sharma, R. P., Janicak, P. G., Davis, J. M., Platelet serotonin-2A receptors: a potential biological marker for suicidal behavior. Am. J. Psychiatry 1995, 152, 850-855.
50. Pandey, G. N., Altered serotonin function in suicide: evidence from platelet and neuroendocrine studies. Ann. NY Acad. Sci. 1997, 836, 182-200.
51. Marazziti, D., De Leo, D., Conti, L., Further evidence supporting the role of the serotonin system in suicidal behavior: a preliminary study of suicide attempters. Acta Psychiatr. Scand. 1989, 80, 322-324.
52. Marazziti, D., Presta, S., Silvestri, S., Battistini, A., Mosti, L., Balestri, C., et al., Platelet markers in suicide attempters. Prog. Neuropsychopharmacol. Biol. Psychiatry 1995, 19, 375-383.
53. Meltzer, H. Y., Arora, R. C., Platelet markers of suicidality. Ann. NY Acad. Sci. 1986, 487, 271-280.
54. Roy, A., Everett, D., Pickar, D., Paul, S. M., Platelet tritiated imipramine binding and serotonin uptake in depressed patients and controls: relationship to plasma cortisol levels before and after dexamethasone administration. Arch. Gen. Psychiatry 1987, 44, 320-327.
55. Mann, J. J., Underwood, M. D., Arango, V., Postmortem studies of suicide victims. In: Watson, S. J. (Ed.), Biology of Schizophrenia and Affective Disease. Washington, DC: American Psychiatric Press, 1996, p. 197-221.
56. Arango, V., Underwood, M. D., Mann, J. J., Postmortem findings in suicide victims: implications for in vivo imaging studies. Ann. NY Acad. Sci. 1997, 836, 269-287.
57. Gross-Isseroff, R., Biegon, A., Voet, H., Weizman, A., The suicide brain: a review of postmortem receptor/transporter binding studies. Neurosci. Biobehav. Rev. 1998, 22, 653-661.
58. Arango, V., Underwood, M. D., Gubbi, A. V., Mann, J. J., Localized alterations in pre-and postsynaptic serotonin binding sites in the ventrolateral prefrontal cortex of suicide victims. Brain Res. 1995, 688, 121-133.
59. Stanley, M., Mann, J. J., Increased serotonin-2 binding sites in frontal cortex of suicide victims. Lancet 1983, 1, 214-216.
60. Hrdina, P. D., Demeter, E., Vu, T. B., Sotonyi, P., Palkovits, M., 5-HT uptake sites and 5-HT2 receptors in brain of antidepressant-free suicide victims/depressives: increase in 5-HT2 sites in cortex and amygdala. Brain Res. 1993, 614, 37-44.
61. Turecki, G., Briere, R., Dewar, K., Antonetti, T., Lesage, A. D., Seguin, M., et al., Prediction of level of serotonin 2A receptor binding by serotonin receptor 2A genetic variation in postmortem brain samples from subjects who did or did not commit suicide. Am.J. Psychiatry 1999, 156, 1456-1458.
62. Owen, F., Chambers, D. R., Cooper, S. J., Crow, T. J., Johnson, J. A., Lofthouse, R., et al., Serotonergic mechanisms in brains of suicide victims. Brain Res. 1986, 362, 185-188.
63. 3H-imipramine binding in the frontal cortex of suicides. Psychiatry Res. 1989, 30, 125-135.
64. Cheetham, S. C., Crompton, M. R., Katona, C. L., Horton, R. W., Brain 5-HT1 binding sites in depressed suicides. Psychopharmacology (Berl.) 1990, 102, 544-548.
65. 3H]ketanserin binding in the human brain postmortem: effect of suicide. Brain Res. 1990, 507, 208-215.
66. Arranz, B., Eriksson, A., Mellerup, E., Plenge, P., Marcusson, J., Brain 5-HT1A, 5-HT1D, and 5-HT2 receptors in suicide victims. Biol. Psychiatry 1994, 35, 457-463.
67. Little, K. Y., McLauglin, D. P., Ranc, J., Gilmore, J., Lopez, J. F., Watson, S. J., et al., Serotonin transporter binding sites and mRNA levels in depressed persons committing suicide. Biol. Psychiatry 1997, 41, 1156-1164.
68. Shallice, T., Burgess, P., The domain of supervisory processes and temporal organization of behaviour. Philos. Trans. R. Soc. Lond. B. Biol. Sci. 1996, 351, 1405-1411.
69. Mann, J. J., The neurobiology of suicide. Nat. Med. 1998, 4, 25-30.
70. Virkkunen, M., Serum cholesterol in antisocial personality. Neuropsychobiology 1979, 5, 27-30.
71. Lipid Research Clinics Program, The Lipid Research Clinics Coronary Primary Prevention Trial results I, Reduction in incidence of coronary heart disease. JAMA 1984, 251, 351-364.
72. Frick, M. H., Elo, O., Haapa, K., Heinonen, O. P., Heinsalmi, P., Helo, P., et al., Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease. N. Engl. J. Med. 1987, 317, 1237-1245.
73. Muldoon, M. F., Manuck, S. B., Matthews, K. A., Lowering cholesterol concentrations and mortality: a quantitative review of primary prevention trials. Br. Med. J. 1990, 301, 309-314.
74. Virkkunen, M., Lipid Research Clinics Coronary Primary Prevention Trial results. JAMA 1985, 253, 635-636.
75. Lindberg, G., Rastam, L., Gullberg, B., Eklund, G. A., Low serum cholesterol concentration and short term mortality from injuries in men and women. Br. Med. J. 1992, 305, 277-279.
76. Neaton, J. D., Blackburn, H., Jacobs, D., Kuller, L., Lee, D. J., Sherwin, R., et al., Serum cholesterol level and mortality findings for men screened in the Multiple Risk Factor Intervention Trial. Multiple Risk Factor Intervention Trial Research Group. Arch. Intern. Med. 1992, 152, 1490-1500.
77. Zureik, M., Courbon, D., Ducimetiere, P., Serum cholesterol concentration and death from suicide in men: Paris prospective study I. Br. Med. J. 1996, 313, 649-651.
78. Partonen, T., Haukka, J., Virtamo, J., Taylor, P. R., Lonnqvist, J., Association of low serum total cholesterol with major depression and suicide. Br. J. Psychiatry 1999, 175, 259-262.
79. Golomb, B. A., Stattin, H., Mednick, S., Low cholesterol and violent crime. J. Psychiatr. Res. 2000, 34, 301-309.
80. Ellison, L. F., Morrison, H. I., Low serum cholesterol concentration and risk of suicide. Epidemiology 2001, 12, 168-172.
81. Freedman, D. S., Byers, T., Barrett, D. H., Stroup, N. E., Eaker, E., Monroe-Blum, H., Plasma lipid levels and psychologic characteristics in men. Am.J. Epidemiol. 1995, 141, 507-517.
82. Iribarren, C., Reed, D. M., Wergowske, G., Burchfiel, C. M., Dwyer, J. H., Serum cholesterol level and mortality due to suicide and trauma in the Honolulu Heart Program. Arch. Intern. Med. 1995, 155, 695-700.
83. Gallerani, M., Manfredini, R., Caracciolo, S., Scapoli, C., Molinari, S., Fersini, C., Serum cholesterol concentrations in parasuicide. Br. Med. J. 1995, 310, 1632-1636.
84. Kunugi, H., Takei, N., Aoki, H., Nanko, S., Low serum cholesterol in suicide attempters. Biol. Psychiatry 1997, 41, 196-200.
85. Alvarez, J. C., Cremniter, D., Lesieur, P., Gregoire, A., Gilton, A., Macquin-Mavier, I., et al., Low blood cholesterol and low platelet serotonin levels in violent suicide attempters. Biol. Psychiatry 1999, 45, 1066-1069.
86. Alvarez, J. C., Cremniter, D., Gluck, N., Quintin, P., Leboyer, M., Berlin, I., et al., Low serum cholesterol in violent but not in non-violent suicide attempters. Psychiatry Res. 2000, 95, 103-108.
87. Garland, M., Hickey, D., Corvin, A., Golden, J., Fitzpatrick, P., Cunningham, S., et al., Total serum cholesterol in relation to psychological correlates in parasuicide. Br. J. Psychiatry 2000, 177, 77-83.
88. Sarchiapone, M., Roy, A., Camardese, G., De Risio, S., Further evidence for low serum cholesterol and suicidal behaviour. J. Affect Disord. 2000, 61, 69-71.
89. Modai, I., Valevski, A., Dror, S., Weizman, A., Serum cholesterol levels and suicidal tendencies in psychiatric inpatients. J. Clin. Psychiatry 1994, 55, 252-254.
90. Sullivan, P. F., Joyce, P. R., Bulik, C. M., Mulder, R. T., Oakley-Browne, M., Total cholesterol and suicidality in depression. Biol. Psychiatry 1994, 36, 472-477.
91. Golier, J. A., Marzuk, P. M., Leon, A. C., Weiner, C., Tardiff, K., Low serum cholesterol level and attempted suicide. Am. J. Psychiatry 1995, 152, 419-423.
92. Mufti, R. M., Balon, R., Arfken, C. L., Low cholesterol and violence. Psychiatr. Serv. 1998, 49, 221-224.
93. New, A. S., Sevin, E. M., Mitropoulou, V., Reynolds, D., Novotny, S. L., Callahan, A., et al., Serum cholesterol and impulsivity in personality disorders. Psychiatry Res. 1999, 85, 145-150.
94. Atmaca, M., Kuloglu, M., Tezcan, E., Gecici, O., Ustundag, B., Serum cholesterol and leptin levels in patients with borderline personality disorder. Neuropsychobiology 2002, 45, 167-171.
95. Virkkunen, M., Serum cholesterol levels in homicidal offenders: a low cholesterol level is connected with a habitually violent tendency under the influence of alcohol. Neuropsychobiology 1983, 10, 65-69.
96. Virkkunen, M., Penttinen, H., Serum cholesterol in aggressive conduct disorder: a preliminary study. Biol. Psychiatry 1984, 19, 435-439.
97. Hillbrand, M., Spitz, R. T., Foster, H. G., Serum cholesterol and aggression in hospitalized male forensic patients. J. Behav. Med. 1995, 18, 33-43.
98. Repo-Tiihonen, E., Halonen, P., Tiihonen, J., Virkkunen, M., Total serum cholesterol level, violent criminal offences, suicidal behavior, mortality and the appearance of conduct disorder in Finnish male criminal offenders with antisocial personality disorder. Eur. Arch. Psychiatry Clin. Neurosci. 2002, 252, 8-11.
99. Apter, A., Laufer, N., Bar-Sever, M., Har-Even, D., Ofek, H., Weizman, A., Serum cholesterol, suicidal tendencies, impulsivity, aggression, and depression in adolescent psychiatric inpatients. Biol. Psychiatry 1999, 46, 532-541.
100. Tanskanen, A., Vartiainen, E., Tuomilehto, J., Viinamaki, H., Lehtonen, J., Puska, P., High serum cholesterol and risk of suicide. Am. J. Psychiatry 2000, 157, 648-650.
101. Golomb, B. A., Cholesterol and violence: is there a connection? Ann. Intern. Med. 1998, 128, 478-487.
102. Ringo, D. L., Lindley, S. E., Faull, K. F., Faustman, W. O., Cholesterol and serotonin: seeking a possible link between blood cholesterol and CSF 5-HIAA. Biol. Psychiatry 1994, 35, 957-959.
103. Steegmans, P. H., Hoes, A. W., Bak, A. A., van der, D. E., Grobbee, D. E., Higher prevalence of depressive symptoms in middle-aged men with low serum cholesterol levels. Psychosom. Med. 2000, 62, 205-211.
104. Muldoon, M. F., Kaplan, J. R., Manuck, S. B., Mann, J. J., Effects of a low-fat diet on brain serotonergic responsivity in cynomolgus monkeys. Biol. Psychiatry 1992, 31, 739-742.
105. Kaplan, J. R., Shively, C. A., Fontenot, M. B., Morgan, T. M., Howell, S. M., Manuck, S. B., et al., Demonstration of an association among dietary cholesterol, central serotonergic activity, and social behavior in monkeys. Psychosom. Med. 1994, 56, 479-484.
106. Engelberg, H., Low serum cholesterol and suicide. Lancet 1992, 339, 727-729.
107. Heron, D. S., Shinitzky, M., Hershkowitz, M., Samuel, D., Lipid fluidity markedly modulates the binding of serotonin to mouse brain membranes. Proc. Natl. Acad. Sci. USA 1980, 77, 7463-7467.
108. Terao, T., Nakamura, J., Yoshimura, R., Ohmori, O., Takahashi, N., Kojima, H., et al., Relationship between serum cholesterol levels and meta-chlorophenyl-piperazine-induced cortisol responses in healthy men and women. Psychiatry Res. 2000, 96, 167-173.
109. Salter, M., Low serum cholesterol and suicide. Lancet 1992, 339, 1169.
110. Penttinen, J., Hypothesis: low serum cholesterol, suicide, and interleukin-2. Am. J. Epidemiol. 1995, 141, 716-718.
111. Baron, D. A., Hardie, T., Baron, S. H., Possible association of interleukin-2 treatment with depression and suicide. J. Am. Osteopath. Assoc. 1993, 93, 799-800.
112. Wilson, D. E., Birchfield, G. R., Hejazi, J. S., Ward, J. H., Samlowski, W. E., Hypocholesterolemia in patients treated with recombinant interleukin-2: appearance of remnant-like lipoproteins. J. Clin. Oncol. 1989, 7, 1573-1577.
113. Lissoni, P., Barni, S., Rovelli, F., Crispino, S., Fumagalli, G., Pescia, S., et al., Neuroendocrine effects of subcutaneous interleukin-2 injection in cancer patients. Tumori 1991, 77, 212-215.
114. Turecki, G., Suicidal behavior: is there a genetic predisposition? Bipolar Disord. 2001, 3, 335-349.
115. Tsuang, M. T., Risk of suicide in the relatives of schizophrenics, manics, depressives, and controls. J. Clin. Psychiatry 1983, 44, 396-400.
116. Brent, D. A., Bridge, J., Johnson, B. A., Connolly, J., Suicidal behavior runs in families: a controlled family study of adolescent suicide victims. Arch. Gen. Psychiatry 1996, 53, 1145-1152.
117. Cheng, A. T., Chen, T. H., Chen, C. C., Jenkins, R., Psychosocial and psychiatric risk factors for suicide: case-control psychological autopsy study. Br. J. Psychiatry 2000, 177, 360-365.
118. Murphy, G. E., Wetzel, R. D., Family history of suicidal behavior among suicide attempters. J. Nerv. Ment. Dis. 1982, 170, 86-90.
119. Pfeffer, C. R., Normandin, L., Kakuma, T., Suicidal children grow up: suicidal behavior and psychiatric disorders among relatives. J. Am. Acad. Child Adolesc. Psychiatry 1994, 33, 1087-1097.
120. Malone, K. M., Haas, G. L., Sweeney, J. A., Mann, J. J., Major depression and the risk of attempted suicide. J. Affect Disord. 1995, 34, 173-185.
121. Johnson, B. A., Brent, D. A., Bridge, J., Connolly, J., The familial aggregation of adolescent suicide attempts. Acta Psychiatr. Scand. 1998, 97, 18-24.
122. Roy, A., Relation of family history of suicide to suicide attempts in alcoholics. Am. J. Psychiatry 2000, 157, 2050-2051.
123. Roy, A., Family history of suicide. Arch. Gen. Psychiatry 1983, 40, 971-974.
124. Linkowski, P., de, M., V, Mendlewicz, J., Suicidal behaviour in major depressive illness. Acta Psychiatr. Scand. 1985, 72, 233-238.
125. Barraclough, B., Bunch, J., Nelson, B., Sainsbury, P., A hundred cases of suicide: clinical aspects. Br. J. Psychiatry 1974, 125, 355-373.
126. Egeland, J. A., Sussex, J. N., Suicide and family loading for affective disorders. JAMA 1985, 254, 915-918.
127. Roy, A., Segal, N. L., Centerwall, B. S., Robinette, C. D., Suicide in twins. Arch. Gen. Psychiatry 1991, 48, 29-32.
128. Roy, A., Segal, N. L., Sarchiapone, M., Attempted suicide among living co-twins of twin suicide victims. Am. J. Psychiatry 1995, 152, 1075-1076.
129. Statham, D. J., Heath, A. C., Madden, P. A., Bucholz, K. K., Bierut, L., Dinwiddie, S. H., et al., Suicidal behaviour: an epidemiological and genetic study. Psychol. Med. 1998, 28, 839-855.
130. Roy, A., Segal, N. L., Suicidal behavior in twins: a replication. J. Affect Disord. 2001, 66, 71-74.
131. Glowinski, A. L., Bucholz, K. K., Nelson, E. C., Fu, Q., Madden, P. A., Reich, W., et al., Suicide attempts in an adolescent female twin sample. J. Am. Acad. Child Adolesc. Psychiatry 2001, 40, 1300-1307.
132. Fu, Q., Heath, A. C., Bucholz, K. K., Nelson, E. C., Glowinski, A. L., Goldberg, J., et al., A twin study of genetic and environmental influences on suicidality in men. Psychol. Med. 2002, 32, 11-24.
133. Schulsinger, F., Kety, S., Rosenthal, D., Wender, P., A family study of suicide. In: Schou, M., Stromgren, E. (Eds.), Origins, Prevention and Treatment of Affective Disorders. New York: Academic Press, 1979, p. 277-287.
134. Wender, P. H., Kety, S. S., Rosenthal, D., Schulsinger, F., Ortmann, J., Lunde, I., Psychiatric disorders in the biological and adoptive families of adopted individuals with affective disorders. Arch. Gen. Psychiatry 1986, 43, 923-929.
135. Nielsen, D. A., Goldman, D., Virkkunen, M., Tokola, R., Rawlings, R., Linnoila, M., Suicidality and 5-hydroxyindoleacetic acid concentration associated with a tryptophan hydroxylase polymorphism. Arch. Gen. Psychiatry 1994, 51, 34-38.
136. Lalovic, A., Turecki, G., Meta-analysis of the association between tryptophan hydroxylase and suicidal behavior. Am.J. Med. Genet. 2002, 114, 533-540.
137. Walther, D. J., Peter, J. U., Bashammakh, S., Hortnagl, H., Voits, M., Fink, H., et al., Synthesis of serotonin by a second tryptophan hydroxylase isoform. Science 2003, 299, 76.
138. Saudou, F., Amara, D. A., Dierich, A., LeMeur, M., Ramboz, S., Segu, L., et al., Enhanced aggressive behavior in mice lacking 5-HT1B receptor. Science 1994, 265, 1875-1878.
139. Huang, Y. Y, Grailhe, R., Arango, V., Hen, R., Mann, J. J., Relationship of psychopathology to the human serotonin1B genotype and receptor binding kinetics in postmortem brain tissue. Neuropsychopharmacology 1999, 21, 238-246.
140. Zhang, H. Y., Ishigaki, T., Tani, K., Chen, K., Shih, J. C., Miyasato, K., et al., Serotonin 2A receptor gene polymorphism in mood disorders. Biol. Psychiatry 1997, 41, 768-773.
141. Du, L., Bakish, D., Lapierre, Y. D., Ravindran, A. V., Hrdina, P. D., Association of polymorphism of serotonin 2A receptor gene with suicidal ideation in major depressive disorder. Am. J. Med. Genet. 2000, 96, 56-60.
142. Geijer, T., Frisch, A., Persson, M. L., Wasserman, D., Rockah, R., Michaelovsky, E., et al., Search for association between suicide attempt and serotonergic polymorphisms. Psychiatr. Genet. 2000, 10, 19-26.
143. Lemonde, S., Turecki, G., Bakish, D., Du, L., Hrdina, P. D., Basak, A., Kushwaha, N., Sequeira, A., Morris, S. J., Ou, X. M., Daigle, M., Albert, P. R., Impaired trans-repression at a 5-HT1A receptor gene polymorphism associated with major depression and suicide. J. Neurosci. 2003, 23, 8788-8799.
144. Bellivier, F., Szoke, A., Henry, C., Lacoste, J., Bottos, C., Nosten-Bertrand, M., et al., Possible association between serotonin transporter gene polymorphism and violent suicidal behavior in mood disorders. Biol. Psychiatry 2000, 48, 319-322.
145. Bondy, B., Erfurth, A., de Jonge, S., Kruger, M., Meyer, H., Possible association of the short allele of the serotonin transporter promoter gene polymorphism (5-HTTLPR) with violent suicide. Mol. Psychiatry 2000, 5, 193-195.
146. Courtet, P., Baud, P., Abbar, M., Boulenger, J. P., Castelnau, D., Mouthon, D., et al., Association between violent suicidal behavior and the low activity allele of the serotonin transporter gene. Mol. Psychiatry 2001, 6, 338-341.
147. Preuss, U. W., Koller, G., Soyka, M., Bondy, B., Association between suicide attempts and 5-HTTLPR S allele in alcohol-dependent and control subjects: further evidence from a German alcohol-dependent inpatient sample. Biol. Psychiatry 2001, 50, 636-639.
148. Anguelova, M., Benkelfat, C., Turecki, G., A systematic review of association studies investigating genes coding for serotonin receptors and the serotonin transporter II, Suicidal behavior. Mol. Psychiatry 2003, 8, 646-653.
149. Lesch, K. P., Bengel, D., Heils, A., Sabol, S. Z., Greenberg, B. D., Petri, S., et al., Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 1996, 274, 1527-1531.
150. Caspi, A., Sugden, K., Moffitt, T. E., Taylor, A., Craig, I. W., Harrington, H., et al., Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science 2003, 301, 386-389.
151. Virkkunen, M., De Jong, J., Bartko, J., Linnoila, M., Psychobiological concomitants of history of suicide attempts among violent offenders and impulsive fire setters. Arch. Gen. Psychiatry 1989, 46, 604-606.
152. Crow, T. J., Cross, A. J., Cooper, S. J., Deakin, J. F., Ferrier, I. N., Johnson, J. A., et al., Neurotransmitter receptors and monoamine metabolites in the brains of patients with Alzheimer-type dementia and depression, and suicides. Neuropharmacology 1984, 23, 1561-1569.
153. Matsubara, S., Arora, R. C., Meltzer, H. Y., Serotonergic measures in suicide brain: 5-HT1A binding sites in frontal cortex of suicide victims. J. Neural Transm. Gen Sect 1991, 85, 181-194.
154. Arango, V., Ernsberger, P., Marzuk, P. M., Chen, J. S., Tierney, H., Stanley, M., et al., Autoradiographic demonstration of increased serotonin 5-HT2 and beta-adrenergic receptor binding sites in the brain of suicide victims. Arch. Gen. Psychiatry 1990, 47, 1038-1047.
155. Guillem, E., Pelissolo, A., Notides, C., Lepine, J. P., Relationship between attempted suicide, serum cholesterol level and novelty seeking in psychiatric in-patients. Psychiatry Res. 2002, 112, 83-88.
156. Vevera, J., Zukov, I., Morcinek, T., Papezova, H., Cholesterol concentrations in violent and non-violent women suicide attempters. Eur. Psychiatry 2003, 18, 23-27.
157. Kaplan, J. R., Manuck, S. B., Shively, C., The effects of fat and cholesterol on social behavior in monkeys. Psychosom. Med. 1991, 53, 634-642.
158. Nishiguchi, N., Shirakawa, O., Ono, H., Nishimura, A., Nushida, H., Ueno, Y., et al., Lack of an association between 5-HT1A receptor gene structural polymorphisms and suicide victims. Am. J. Med. Genet. 2002, 114, 423-425.
159. Nishiguchi, N., Shirakawa, O., Ono, H., Nishimura, A., Nushida, H., Ueno, Y., et al., No evidence of an association between 5HT1B receptor gene polymorphism and suicide victims in a Japanese population. Am. J. Med. Genet. 2001, 105, 343-345.
160. Turecki, G., Sequeira, A., Gingras, Y., Seguin, M., Lesage, A., Tousignant, M., et al., Suicide and serotonin: study of variation at seven serotonin receptor genes in suicide completers. Am. J. Med. Genet. 2003, 118B, 36-40.
161. Rujescu, D., Giegling, I., Sato, T., Moller, H. J., Lack of association between serotonin 5-HT1B receptor gene polymorphism and suicidal behavior. Am. J. Med. Genet. 2003, 116B, 69-71.
162. Huang, Y. Y., Oquendo, M. A., Friedman, J. M., Greenhill, L. L., Brodsky, B., Malone, K. M., et al., Substance abuse disorder and major depression are associated with the human 5-HT1B receptor gene (HTR1B) G861C polymorphism. Neuropsychopharmacology 2003, 28, 163-169.
163. Ohara, K., Nagai, M., Tsukamoto, T., Tani, K., Suzuki, Y., Ohara, K., 5-HT2A receptor gene promoter polymorphism: 1438G/A and mood disorders. Neuroreport 1998, 9, 1139-1141.
164. Du, L., Faludi, G., Palkovits, M., Demeter, E., Bakish, D., Lapierre, Y. D., et al., Frequency of long allele in serotonin transporter gene is increased in depressed suicide victims. Biol. Psychiatry 1999, 46, 196-201.
165. Tsai, S. J., Hong, C. J., Hsu, C. C., Cheng, C. Y., Liao, W. Y., Song, H. L., et al., Serotonin-2A receptor polymorphism (102T/C) in mood disorders. Psychiatry Res. 1999, 87, 233-237.
166. Preuss, U. W., Koller, G., Bahlmann, M., Soyka, M., Bondy, B., No association between suicidal behavior and 5-HT2A-T102C polymorphism in alcohol dependents. Am. J. Med. Genet. 2000, 96, 877-878.
167. Crawford, J., Sutherland, G. R., Goldney, R. D., No evidence for association of 5-HT2A receptor polymorphism with suicide. Am. J. Med. Genet. 2000, 96, 879-880.
168. Bondy, B., Kuznik, J., Baghai, T., Schule, C., Zwanzger, P., Minov, C., et al., Lack of association of serotonin-2A receptor gene polymorphism (T102C) with suicidal ideation and suicide. Am.J. Med. Genet. 2000, 96, 831-835.
169. Ono, H., Shirakawa, O., Nishiguchi, N., Nishimura, A., Nushida, H., Ueno, Y., et al., Serotonin 2A receptor gene polymorphism is not associated with completed suicide. J. Psychiatr. Res. 2001, 35, 173-176.
170. Arias, B., Gasto, C., Catalan, R., Gutierrez, B., Pintor, L., Fananas, L., The 5-HT (2A) receptor gene 102T/C polymorphism is associated with suicidal behavior in depressed patients. Am. J. Med. Genet. 2001, 105, 801-804.
171. Correa, H., De Marco, L., Boson, W., Viana, M. M., Lima, V. F., Campi-Azevedo, A. C., et al., Analysis of T102C 5HT2A polymorphism in Brazilian psychiatric inpatients: relationship with suicidal behavior. Cell Mol. Neurobiol. 2002, 22, 813-817.
172. Chong, S. A., Lee, W. L., Tan, C. H., Tay, A. H., Chan, A. O., Tan, E. C., Attempted suicide and polymorphism of the serotonin transporter gene in Chinese patients with schizophrenia. Psychiatry Res. 2000, 97, 101-106.
173. Gorwood, P., Batel, P., Ades, J., Hamon, M., Boni, C., Serotonin transporter gene polymorphisms, alcoholism, and suicidal behavior. Biol. Psychiatry 2000, 48, 259-264.
174. Russ, M. J., Lachman, H. M., Kashdan, T., Saito, T., Bajmakovic-Kacila, S., Analysis of catechol-O-methyltransferase and 5-hydroxytryptamine transporter polymorphisms in patients at risk for suicide. Psychiatry Res. 2000, 93, 73-78.
175. Fitch, D., Lesage, A., Seguin, M., Trousignant, M., Bankelfat, C., Rouleau, G. A., et al., Suicide and the serotonin transporter gene. Mol. Psychiatry 2001, 6, 127-128.
176. Rujescu, D., Giegling, I., Sato, T., Moeller, H. J., A polymorphism in the promoter of the serotonin transporter gene is not associated with suicidal behavior. Psychiatr. Genet. 2001, 11, 169-172.
177. Baca-Garcia, E., Vaquero, C., Diaz-Sastre, C., Saiz-Ruiz, J., Fernandez-Piqueras, J., de Leon, J., A gender-specific association between the serotonin transporter gene and suicide attempts. Neuropsychopharmacology 2002, 26, 692-695.
178. Bayle, F. J., Leroy, S., Gourion, D., Millet, B., Olie, J. P., Poirier, M. F., et al., 5HTTLPR polymorphism in schizophrenic patients: further support for association with violent suicide attempts. Am. J. Med. Genet. 2003, 119B, 13-17.
179. Courtet, P., Buresi, C., Abbar, M., Baud, P., Boulenger, J. P., Castelnau, D., et al., No association between non-violent suicidal behavior and the serotonin transporter promoter polymorphism. Am. J. Med. Genet. 2003, 116B, 72-76.